-
The mutational landscape of primary central nervous system lymphoma (Hipo H050, A050, XD013)
Study
EGAS00001005339
-
Single cell exome sequencing of lung adenocarcinoma
Study
EGAS00001002972
-
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
Study
EGAS00001004349
-
Dissecting intratumor heterogeneity of nodal B cell lymphoma on the transcriptional, genetic, and drug response level
Study
EGAS00001004335
-
Molecular determinants of response to PD-L1 blockade across tumor types
Study
EGAS00001004343
-
Myeloma WGS
Study
EGAS00001004000
-
RNA sequencing of CD8 T cells from melanoma patients prior to and during checkpoint immunotherapy and untreated healthy controls
Study
EGAS00001004081
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
Whole genome bisulfite sequencing on 10 multiple myeloma cases
Study
EGAS00001004346
-
Single-cell RNA sequencing of 22 Hodgkin lymphoma tumors and 5 reactive lymph nodes
Study
EGAS00001004085
-
Host whole genome variations are associated with neurocognitive outcome in survivors of pediatric medulloblastoma
Study
EGAS00001002996
-
Bulk RNAseq gene expression of baseline tumors from metastatic urothelial bladder cancer patients (IMvigor210) and metastatic renal cell carcinoma (IMmotion150)
Study
EGAS00001004386
-
Whole genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Study
EGAS00001004379
-
Multi-omics of Richter syndrome
Study
EGAS00001005495
-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Study
EGAS00001004422
-
Cell type-specific transcriptomics of esophageal adenocarcinoma as a scalable alternative for single cell transcriptomics
Study
EGAS00001004053
-
Pancreatic tropism of metastatic renal cell carcinoma
Study
EGAS00001004208
-
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
Study
EGAS00001005420
-
Patient-derived neuroblastoma model system OHC-NB1
Study
EGAS00001003031
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell RCC-- CA209-025
Study
EGAS00001004292
-
A Single-Cell Atlas of the Multicellular Ecosystem of Primary and Metastatic Hepatocellular Carcinoma
Study
EGAS00001004468
-
H3.3G34R/V-transformed interneuron progenitors co-opt PDGFRA for gliomagenesis
Study
EGAS00001004301
-
Whole genome sequencing (bam files) of 5 samples of myxofibrosarcoma and 5 matched pairs
Study
EGAS00001005444
-
MM samples for epigenomic translocation of H3K4me3 broad domains following super-enhancer hijacking
Study
EGAS00001005684
-
Persistent STAG2 mutation in recurrent pediatric glioblastoma
Study
EGAS00001004340
-
Cell-free DNA fragmentation patterns and personalized sequencing reveal circulating tumor DNA in urine and plasma of glioma patients
Study
EGAS00001004355
-
IMCISION DNAseq
Study
EGAS00001005466
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126
-
Cancer immune control needs senescence induction by Stat1 dependent cell cycle regulator pathways in tumours
Study
EGAS00001004151
-
A Multifactorial Tumor and Immune Cell Profile Determines Response to Immune Checkpoint blockade in Melanoma
Study
EGAS00001004548
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders
Study
EGAS00001005520
-
'KOREAN' never-smoker female adenocarcinoma RNA-seq
Study
EGAS00001003789
-
Transcriptional changes in GBM through therapy
Study
EGAS00001003790
-
Targeted sequencing data and shallow whole genome sequencing data of Follicular lymphoma.
Study
EGAS00001005755
-
Mutational landscape of eccrine porocarcinoma (sweat gland tumour)
Study
EGAS00001004632
-
The genomic landscape of early stage ovarian high grade serous carcinoma
Study
EGAS00001005567
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit - 10x Genomics scRNAseq
Study
EGAS00001005098
-
Targeted sequencing of Burkitt lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001004649
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005581
-
Whole genome sequencing of multiple myeloma identifies novel structural and non-coding mutations.
Study
EGAS00001003164
-
Integrative molecular analysis of pediatric Anaplastic large cell lymphoma reveals subtypes with distinct immune suppression signatures.
Study
EGAS00001004189
-
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
Study
EGAS00001004763
-
Analysis of exonic somatic variants in light-chain amyloidosis (ALA) and ALA concomitant with multiple myeloma
Study
EGAS00001004214
-
Analysis of IDHwt-glioblastoma samples from paired primary and recurrent tumor samples
Study
EGAS00001003184